ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO368

Cardiovascular Morbidity Patterns in Patients on Dialysis Globally in Apollo Dial DB

Session Information

Category: Hypertension and CVD

  • 1602 Hypertension and CVD: Clinical

Authors

  • Alejos, Belen, Fresenius Medical Care, Bad Homburg, Hessen, Germany
  • Croft, Kaitlyn Renee, Fresenius Medical Care, Bad Homburg, Hessen, Germany
  • Jiao, Yue, Fresenius Medical Care, Waltham, Massachusetts, United States
  • Wolf, Melanie, Fresenius Medical Care, Bad Homburg, Hessen, Germany
  • Carioni, Paola, Fresenius Medical Care, Crema, Italy
  • Soni, Mitesh, Fresenius Medical Care, Waltham, Massachusetts, United States
  • Winter, Anke, Fresenius Medical Care, Bad Homburg, Hessen, Germany
  • Neri, Luca, Fresenius Medical Care, Crema, Italy
  • Chaudhuri, Sheetal, Fresenius Medical Care, Waltham, Massachusetts, United States
  • Singh, Kanti, Fresenius Medical Care, Waltham, Massachusetts, United States
  • Stuard, Stefano, Fresenius Medical Care, Crema, Italy
  • Nikam, Milind, Fresenius Medical Care, Singapore, Singapore
  • Guinsburg, Adrian M., Fresenius Medical Care, Buenos Aires, Argentina
  • Chatoth, Dinesh K., Fresenius Medical Care, Waltham, Massachusetts, United States
  • Hymes, Jeffrey L., Fresenius Medical Care, Waltham, Massachusetts, United States
  • Koulechov, Kirill, Fresenius Medical Care, Bad Homburg, Hessen, Germany
  • Usvyat, Len A., Fresenius Medical Care, Waltham, Massachusetts, United States
  • Larkin, John W., Fresenius Medical Care, Waltham, Massachusetts, United States
  • Maddux, Franklin W., Fresenius Medical Care AG, Bad Homburg, Hessen, Germany
Background

Cardiovascular diseases (CVDs) affect most people with kidney failure but are undefined globally. We aimed to analyze CVD prevalence among dialysis patients treated in 40 countries across six continents, as represented in the first version of a global dialysis database (Apollo Dial DB).

Methods

Apollo Dial DB includes adult dialysis patient data from a global kidney network during Jan 2018-Mar 2021 (Fresenius Medical Care, Bad Homburg, DE). Data anonymization was performed in alignment with recommendations from a re-identification risk determination (Privacy Analytics, Ontario, CA). This analysis assessed CVD comorbidities based on ICD-10 codes.

Results

Among 543,169 patients included, 79% reported ≥1 CVD condition. The prevalence of CVD conditions showed some differences by age and sex (Figure 1). Hypertension was the most common, affecting 73.6% of patients. Atherosclerotic heart disease affected 19.0%, increasing with age (9.9% in 18-44 years to 24.1% in ≥75) and more common in males (20.3%) than females (17.2%). Congestive heart failure affected 17.5%, also increasing with age. Other conditions included peripheral vascular disease (11.5%), cardiomyopathy (7.3%), and cardiac dysrhythmias (7.1%), all more prevalent in older age groups and slightly higher in males.

Conclusion

Hypertension is the most common CVD comorbidity among dialysis patients globally, followed by atherosclerotic heart disease and congestive heart failure. The prevalence of these conditions increases with age and is slightly higher in males. Future analyses are needed to explore differences by world region, which could inform region-specific management strategies.

Figure 1: Distribution of cardiovascular diseases by age group and gender

Funding

  • Commercial Support – Fresenius Medical Care